醫師簡介

周詠欽 外科部部主任

外科部部主任 泌尿外科主任

現 任:

嘉義基督教醫院外科部部主任

嘉義基督教醫院泌尿外科科主任

嘉義基督教醫院器官移植小組召集人

嘉義基督教醫院泌尿外科主治醫師

亞洲大學食品營養與保健生技學系副教授


學經歷:中山醫學大學醫學系畢
    台中榮總外科醫師
    成大醫院泌尿外科醫師
    泌尿科專科醫師
    美國匹茲堡大學研究員
    教育部定副教授
    成功大學醫學系兼任助理教授
    曾任樹人醫專兼任講師
    曾任崇仁專校兼任講師

專 長:泌尿道結石
    腎臟移植
    輸尿管、膀胱腫瘤

  • Ya-Che Lee, Yeong-Chin Jou, Ming-Chin Cheng, Cheng-Huang Shen, Chang-Te Lin, Tubeless mini-percutaneous nephrolithotomy for the treatment of renal and upper ureteral stones of ≥3 cm in diameter. Urological Science 2020
  • Shu-Chuan Hsiao, Yeong-Chin Jou, Ming-Chin Cheng, Cheng-Huang Shen, Chang-Te Lin, Pi-Che Chen, Wei-Hong Lai, Pei-Yi Chen, Safety and efficacy of percutaneous nephrolithotomy in patients with large stones: A retrospective study. Urological Science 2019
  • Yeong‑Chin Jou, Shou‑Chieh Wang, Yuan‑Chang Dai, Shih‑Ying Chen, Cheng‑Huang Shen, Ying‑Ray Lee, Lei‑Chin Chen and Yi‑Wen Liu, Gene expression and DNA methylation regulation of arsenic in mouse bladder tissues and in human urothelial cells. Oncol Rep. 2019 Sep;42(3):1005-1016. doi: 10.3892/or.2019.7235. Epub 2019 Jul 16.
  • Jou, Y. C., Tsai, Y. S., Lin, C. T., Tung, C. L., Shen, C. H., Tsai, H. T (2019) Cancer Science, Prothymosin-α Enhances PTEN Expression and Binds with TRIM21 to Regulate Keap1/Nrf2 Signaling in Human Bladder
  • Hsiao-Yen Hsieh, Yeong-Chin Jou, Chun-Liang Tung, Yuh-Shyan Tsai, Yuan-Hung Wang, Chen-Lin Chi, Ru-Inn Lin, Shih-Kai Hung, Yu-Ming Chuang, Shu-Fen Wu, Chin Li, Cheng-Huang Shen, Michael W.Y. Chan, Cheng-Da Hsu (2017) Oncogene, 37(5).673 Epigenetic silencing of the dual-role signal mediator, ANGPTL4 in tumor tissues and its overexpression in the urothelial carcinoma microenvironment.
  • Yang, C. Y., Chen, P. C., Lin, C. L., Cheng, M. C., Jou, Y. C., & Shen, C. H. (2017). Prophylactic antibiotics for tubeless percutaneous nephrolithotomy.Formosan Journal of Surgery, 50(3), 97.
  • Chang, S. K., Jou, Y. C., Tong, S. H., Lin, Y. F., Kuo, Y. L., & Wu, J. F. (2017). Cytomegalovirus infection in a kidney transplantation patient presented with skin lesion. Formosan Journal of Surgery, 50(3), 114.
  • Chang, C. H., Jou, Y. C., Wu, C. H., & Hsieh, C. W. (2017). Pneumomediastinum: An unusual complication after percutaneous nephrolithotomy. Tzu Chi Medical Journal, 29(2), 118.
  • Jou, Y. C., Tsai, Y. S., Lin, C. T., Tung, C. L., Shen, C. H., Tsai, H. T., ... & Tzai, T. S. (2016). Foxp3 enhances HIF-1α target gene expression in human bladder cancer through decreasing its ubiquitin-proteasomal degradation.Oncotarget, 7(40), 65403.
  • Jou, Y. C., Tsai, Y. S., Chen, S. Y., Hsieh, H. Y., Tsai, H. T., & Tzai, T. S. (2016). Loss of DAB2IP expression in human urothelial carcinoma is associated with poorer recurrence-free survival. Virchows Archiv, 468(6), 733-740
  • Lai, W. H., Jou, Y. C., Cheng, M. C., Shen, C. H., Lin, C. T., Chen, P. C., ... & Chen, C. C. (2017). Tubeless percutaneous nephrolithotomy: Experience of 1000 cases at a single institute. Urological Science, 28(1), 23-26.
  • Tsai, Y. S., Jou, Y. C., Tung, C. L., Lin, C. T., Shen, C. H., Chen, S. Y., ... & Tzai, T. S. (2014). Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer. Virchows Archiv,464(6), 717-724
  • Jou, Y. C., Lu, C. L., Chen, F. H., Shen, C. H., Cheng, M. C., Lin, S. H., ... & Li, Y. H. (2015). Contributing factors for fever after tubeless percutaneous nephrolithotomy. Urology, 85(3), 527-530.
  • Tsai, Y. S., Jou, Y. C., Tung, C. L., Lin, C. T., Shen, C. H., Chen, S. Y., ... & Tzai, T. S. (2014). Virchows Archiv,464(6), 717-724..Loss of nuclear prothymosin-α expression is associated with disease progression in human superficial bladder cancer.
  • Tsai, Y. S., Jou, Y. C., Chen, C. H., Chang, C. C., Yang, W. H., Lai, J. L., & Tzai, T. S. (2014). Journal of endourology, 28(3), 364-370. Doppler spectral waveform parameters at neurovascular bundle vessels in patients with prostate biopsy.
  • Jou, Yeong-Chin, et al. Urology 83.5 (2014): 1006-1010."Age-dependent association between Dickkopf-1 and calcium-containing urolithiasis."
  • Jou, Y. C., Tsai, Y. S., Hsieh, H. Y., Chen, S. Y., Tsai, H. T., Chen, K. J., ... & Tzai, T. S. (2013, November). Urologic Oncology: Seminars and Original Investigations . 31: 1806-1811). Elsevier.Plasma thymosin-α1 level as a potential biomarker in urothelial and renal cell carcinoma.
  • Chang, S. K., Cheong, I. S., Cheng, M. C., Jou, Y. C., Chen, C. C., & Hu, M. M. (2019). Pressure compression of the access tract for tubeless percutaneous nephrolithotomy. Urological Science, 30(1), 19.
  • Yang, C. Y., Chen, P. C., Lin, C. L., Cheng, M. C., Jou, Y. C., & Shen, C. H. (2017). Prophylactic antibiotics for tubeless percutaneous nephrolithotomy. Formosan Journal of Surgery, 50(3), 97.
  • Chang, C. H., Jou, Y. C., Wu, C. H., & Hsieh, C. W. (2017). Pneumomediastinum: An unusual complication after percutaneous nephrolithotomy. Tzu Chi Medical Journal, 29(2), 118.
  • Lai, W. H., Jou, Y. C., Cheng, M. C., Shen, C. H., Lin, C. T., Chen, P. C., ... & Chen, C. C. (2017). Tubeless percutaneous nephrolithotomy: Experience of 1000 cases at a single institute. Urological Science, 28(1), 23-26.
  • Jou, Y. C., Lu, C. L., Chen, F. H., Shen, C. H., Cheng, M. C., Lin, S. H., ... & Li, Y. H. (2015). Contributing factors for fever after tubeless percutaneous nephrolithotomy. Urology, 85(3), 527-530. (SCI)
  • Yeong-Chin Jou, Yuh-Shyan TsaiHsiao-Yen Hsieh, Cheng-Huang Shen,, Chiung-Yao Fang., Syue-Yi Chen, Ming-Fu Lin, Fang-Hung Chen, Cheng-Da Hsu Age-dependant association between Dickkopf-1 and calcium-containing urolithiasis Urology 2014 (SCI)
  • Yeong-Chin Jou, Fang-Hung Chen, Cheng-Huang Shen Mass spectrometry study of stone matrix protein of human uric acid bladder stone Urology 82(4) 2013 (SCI)
  • Yeong-Chin Jou, Chiung-Yao Fang, Syue-Yi Chen, Fang-Hung Chen, Ming-Chin Cheng, Cheng-Huang Shen, Li-Wen Liao, and Yuh-Shyan Tsai Proteomic Study of Renal Uric Acid Stone Urology, 80(2) 2012 (SCI)
  • Yeong-Chin Jou, Chang-Te Lin, Ming-Chin Cheng, Pe-Che Chen, Chang-Huang Shen Safety and efficacy of tubeless percutaneous nephrolithotomy after tract cauterization in patients on anti-platelet therapy and cirrhotic patients. Urologic Research, 39:393-396, 2011 (SCI)
  • Yeong-Chin Jou, Chang-Te Lin, Ming-Chin Cheng, Pe-Che Chen, Chang-Huang Shen Tubeless Percutaneous Nephrolithotomy for Geriatric Patients Urol Int; 82: 346-349, 2009 (SCI)
  • Lin CT; Shen CH; Cheng MC; Jou YC; Chen PC Delayed Hydrothorax after Tubeless Percutaneous Nephrolithotomy Formosan J Surg, 7:472-3, 2007
  • Yeong-Chin Jou, Ming-Chin Cheng, Chang-Te Lin, Pe-Che Chen, Chang-Huang Shen Delayed Pneumothorax after Tubeless Percutaneous Nephrolithotomy Surg Laparo Endosc Percuta Tech 17:472-473, 2007 (SCI)
  • Shen CH; Cheng MC; Lin CT; Jou YC; Chen PC Innovative Metal Dilators for Percutaneous Nephrostomy Tract: Report on 546 Cases Urology, 69:22-26, 2007 (SCI)
  • Yeong-Chin Jou, Chang-Huang Shen, Ming-Chin Cheng, Chang-Te Lin, Pe-Che Chen High power holmium:YAG laser for the treatment of large renal stones percutaneously. Urology, 70:418-421, , 2007 (SCI)
  • Yeong-Chin Jou, Ming-Chin Cheng, Chang-Te Lin, Pe-Che Chen, Jang-Huang Shen Nephrostomy Tube-free Percutaneous Nephrolithotomy for Patients with Large stones and Staghorn Stones. Urology 67:30-34, 2006 (SCI)
  • Yeong-Chin Jou, Ming-Chin Cheng, Chang-Te Lin, Pe-Che Chen, Jang-Huang SheenPercutaneous Nephrolithotomy with Holmium:YAG Laser and a Fiber Guider – Report of 349 Cases Urology; 65: 454-458, 2004 (SCI)
  • Yeong-Chin Jou, Ming-Chin Cheng, Chang-Te Lin, Pe-Che Chen, Jang-Huang Sheen Electrocauterization of Bleeding Points for Percutaneous Nephrolithotomy. Urology;64:443-446, 2004 (SCI)
  • Yeong-Chin Jou, Ming-Chin Cheng, Chang-Te Lin, Pe-Che Chen, Jang-Huang Shen Cauterization of Access Tract for Nephrostomy Tube Free Percutaneous Nephrostolithotomy J of Endourol;18:544-546, 2004 (SCI)

泌尿外科

  • 沈正煌
    醫療長
  • 周詠欽
    外科部部主任
  • 陳丕哲
    主治醫師
  • 鄭明進
    碎石中心主任
  • 林昌德
    主治醫師
  • 賴韋宏
    主治醫師
  • 陳柏仲
    主治醫師
  • 張恩承
    主治醫師
Back to top